Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

The chapter explains that there are many genetic skin disorders affecting skin cell formation, including both common and rare types.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Many substances, including chemicals and metals, can cause skin reactions; careful handling and identification of allergens are crucial to prevent dermatitis.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Nanotechnology improves cosmetics' effectiveness and safety.

Personalized treatment plans are important for people with alopecia areata.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

New psoriasis treatments are effective but come with side effects and risks.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

A woman with anorexia nervosa improved after treatment for pellagra, reminding doctors to check for this deficiency in patients with eating disorders.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that supportive home environments and addressing parent-child interactions can effectively treat trichotillomania in children.